Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Current Rheumatology Reports|May 15, 2012
Data quality challenges in systemic lupus erythematosus trials: how can this be optimized?Marilyn C Pike, Lexy KelleyBMC Musculoskeletal Disorders|October 12, 2010
Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritisDavid J Hunter, Marilyn C Pike, Beth L Jonas, et al.Rheumatology (Oxford, England)|November 26, 2013
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006Vibeke Strand, Michelle Petri, Kenneth Kalunian, et al.Annals of the Rheumatic Diseases|January 15, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre studyDaniel J Wallace, Kenneth Kalunian, Michelle A Petri, et al.Rheumatology (Oxford, England)|April 2, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-upDaniel J Wallace, Caroline Gordon, Vibeke Strand, et al.Arthritis & Rheumatology (Hoboken, N.J.)|September 7, 2016
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled TrialsMegan E B Clowse, Daniel J Wallace, Richard A Furie, et al.Pageof 1